store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
QL47 是一种宿主靶向的小分子抗病毒剂,具有抗病毒活性,对登革热病毒和其他 RNA 病毒有抑制作用。QL47 可作为病毒翻译的抑制抑制剂和 BTK 的共价抑制剂,可用于研究淋巴瘤。
产品描述 | QL47 is a host-targeted small molecule antiviral agent with antiviral activity against dengue and other RNA viruses.QL47 acts as an inhibitor of viral translation and a covalent inhibitor of BTK, and can be used in the study of lymphomas. |
靶点活性 | Tyr223:475 nM (EC50), PLCγ2/Tyr 759:318 nM |
体外活性 | QL47 inhibits protein neosynthesis initiated by both canonical cap-driven and noncanonical initiation strategies, most likely by targeting an early step in translation elongation[2].QL47, with an EC50 of 475 nM, inhibits the autophosphorylation of BTK on Tyr223 in cells and, with an EC50 of 318 nM, inhibits the phosphorylation of a downstream effector PLCγ2 (Tyr759). In Ramos cells, QL47 induces a G1 cell cycle arrest that is associated with pronounced degradation of BTK protein. Furthermore, QL47 inhibits the proliferation of B-cell lymphoma cancer cell lines at submicromolar concentrations[1]. |
分子量 | 447.49 |
分子式 | C27H21N5O2 |
CAS No. | 1469988-75-7 |
store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 1 mg/mL (2.23 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.2347 mL | 11.1734 mL | 22.3469 mL | 55.8672 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
QL47 1469988-75-7 Angiogenesis Microbiology/Virology Tyrosine Kinase/Adaptors Virus Protease BTK QL 47 QL-47 Inhibitor inhibitor inhibit